CMI’Nov – ACCUEIL anglais

Minimally invasive ANNULOPLASTY
for the treatment of MITRAL REGURGITATION

Mitral Regurgitation

Mitral regurgitation is one of the most frequent, hard to treat and deadly chronic condition associated with heart failure.

Product

Mit’rep: an opportunity to offer valve repair to many patients currently ineligible for minimally invasive treatments.

LATEST NEWS

A 17M€ project running over 5 years ( 5,5M€ of which are granted by the "Programme d'Investissement d'Avenir") to develop a complete solution for mitral valve annuloplasty repair by transcatheter using the latest imaging and assisted robotics technologies.

Chosen among 89 projects competing for the RHU 2021 (University Hospital Research Program), ICELAND* aims to facilitate access to surgical management for the largest number of patients suffering from mitral regurgitation.